Shigeto Kitamura

529 total citations
24 papers, 440 citations indexed

About

Shigeto Kitamura is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Shigeto Kitamura has authored 24 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Physiology and 6 papers in Organic Chemistry. Recurrent topics in Shigeto Kitamura's work include Asthma and respiratory diseases (8 papers), Synthesis and Biological Evaluation (4 papers) and Allergic Rhinitis and Sensitization (3 papers). Shigeto Kitamura is often cited by papers focused on Asthma and respiratory diseases (8 papers), Synthesis and Biological Evaluation (4 papers) and Allergic Rhinitis and Sensitization (3 papers). Shigeto Kitamura collaborates with scholars based in Japan. Shigeto Kitamura's co-authors include Shunji Ichikawa, Kôji Yamada, Yoshihisa Kuwana, Shizuo Shiozaki, Joji Nakamura, Hiroshi Kase, Takao Iida, Kunikatsu Shirahata, Haruhiko Manabe and Kenji Ohmori and has published in prestigious journals such as FEBS Letters, Journal of Medicinal Chemistry and European Journal of Biochemistry.

In The Last Decade

Shigeto Kitamura

23 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeto Kitamura Japan 11 171 123 104 96 95 24 440
Jason M. Conley United States 12 283 1.7× 49 0.4× 84 0.8× 27 0.3× 23 0.2× 26 443
Yu Jin Hwang South Korea 14 346 2.0× 23 0.2× 185 1.8× 71 0.7× 9 0.1× 29 689
Andrea Spinaci Italy 12 186 1.1× 187 1.5× 39 0.4× 14 0.1× 70 0.7× 33 325
Thomas P. Kemmer Germany 13 273 1.6× 56 0.5× 75 0.7× 21 0.2× 39 0.4× 24 516
Kuehl Fa 7 180 1.1× 25 0.2× 67 0.6× 6 0.1× 16 0.2× 10 388
Isabelle Delton‐Vandenbroucke France 12 258 1.5× 28 0.2× 40 0.4× 7 0.1× 17 0.2× 16 501
Hyo Sang Jo South Korea 14 269 1.6× 12 0.1× 47 0.5× 31 0.3× 15 0.2× 23 457
Luke J. Haslett United Kingdom 5 139 0.8× 117 1.0× 34 0.3× 38 0.4× 21 0.2× 5 437
Violetta N. Pivtoraiko United States 5 196 1.1× 38 0.3× 41 0.4× 71 0.7× 8 0.1× 6 447
Monika Bozem Germany 12 292 1.7× 63 0.5× 124 1.2× 6 0.1× 9 0.1× 16 585

Countries citing papers authored by Shigeto Kitamura

Since Specialization
Citations

This map shows the geographic impact of Shigeto Kitamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeto Kitamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeto Kitamura more than expected).

Fields of papers citing papers by Shigeto Kitamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeto Kitamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeto Kitamura. The network helps show where Shigeto Kitamura may publish in the future.

Co-authorship network of co-authors of Shigeto Kitamura

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeto Kitamura. A scholar is included among the top collaborators of Shigeto Kitamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeto Kitamura. Shigeto Kitamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshida, Masanori, et al.. (2007). Effect of concomitant treatment with a CYP3A4 inhibitor and a calcium channel blocker. Pharmacoepidemiology and Drug Safety. 17(1). 70–75. 15 indexed citations
2.
Shiozaki, Shizuo, Shunji Ichikawa, Joji Nakamura, et al.. (1999). Actions of adenosine A 2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP. Psychopharmacology. 147(1). 90–95. 189 indexed citations
3.
Manabe, Haruhiko, et al.. (1997). Anti-inflammatory and bronchodilator properties of KF19514, a phosphodiesterase 4 and 1 inhibitor. European Journal of Pharmacology. 332(1). 97–107. 17 indexed citations
4.
Ikemura, Toshihide, Haruhiko Manabe, Yasuo Sasaki, et al.. (1996). KW-4679, an Antiallergic Drug, Inhibits the Production of Inflammatory Lipids in Human Polymorphonuclear Leukocytes and Guinea Pig Eosinophils. International Archives of Allergy and Immunology. 110(1). 57–63. 23 indexed citations
5.
Ohmori, Kenji, Hidee Ishii, Yasuo Sasaki, et al.. (1996). Effects of KW-4679, a New Orally Active Antiallergic Drug, on Antigen-Induced Bronchial Hyperresponsiveness, Airway Inflammation and Immediate and Late Asthmatic Responses in Guinea Pigs. International Archives of Allergy and Immunology. 110(1). 64–72. 18 indexed citations
6.
Ikemura, Toshihide, Kenji Ohmori, Takeo Tanaka, Yuzuru Matsuda, & Shigeto Kitamura. (1996). Effects of Endothelin B Antagonist RES−701−1 on Endothelin-induced Contractile Responses In-vivo and In-vitro in Guinea-pigs. Journal of Pharmacy and Pharmacology. 48(1). 100–105. 3 indexed citations
7.
8.
9.
Ishii, Hidee, Shigeto Kitamura, & Kenji Ohmori. (1993). Inhibition of antigen-induced late asthmatic response and airway inflammation by KW-4679.. The Japanese Journal of Pharmacology. 61. 228–228. 3 indexed citations
10.
Suzuki, Fumio, Takeshi Kuroda, Haruhiko Manabe, et al.. (1992). New bronchodilators. 1. 1,5-Substituted 1H-imidazo[4,5-c]quinolin-4(5H)-ones. Journal of Medicinal Chemistry. 35(22). 4045–4053. 24 indexed citations
11.
Suzuki, Fumio, Takeshi Kuroda, Takashi Kawakita, et al.. (1992). New bronchodilators. 3. Imidazo[4,5-c][1,8]naphthyridin-4(5H)-ones. Journal of Medicinal Chemistry. 35(26). 4866–4874. 21 indexed citations
12.
Suzuki, Fumio, Takeshi Kuroda, Hiroaki Hayashi, et al.. (1992). New Bronchodilators. II. 3H-Imidazo(4,5-c)quinolin-4(5H)-ones.. Chemical and Pharmaceutical Bulletin. 40(12). 3245–3252. 4 indexed citations
13.
Manabe, Haruhiko, et al.. (1992). Pharmacological properties of a new bronchodilator, KF17625. The Japanese Journal of Pharmacology. 58. 238–238. 1 indexed citations
14.
Sasaki, Yasuo, et al.. (1990). Pharmacological properties of KW-4099, a new antiallergic agent with TXA2 antagonistic activity. The Japanese Journal of Pharmacology. 52. 122–122. 1 indexed citations
15.
Kitamura, Shigeto, Takao Shimizu, Ichiro Miki, et al.. (1988). Synthesis and structural identification of four dihydroxy acids and 11, 12‐leukotriene C4 derived from 11, 12‐leukotriene A4. European Journal of Biochemistry. 176(3). 725–731. 19 indexed citations
16.
Kitamura, Shigeto, et al.. (1988). Biochemical and Pharmacological Properties of 5-Lipoxygenase Inhibitor KF8940. Agricultural and Biological Chemistry. 52(12). 3131–3136. 1 indexed citations
17.
Kitamura, Shigeto, Takao Shimizu, Takashi Izumi, & Yousuke Seyama. (1987). Synthesis of 11,12‐leukotriene A4, 11S,12S‐oxido‐5Z,7E,9E,14Z‐eicosatetraenoic acid, a novel leukotriene of the 12‐lipoxy genase pathway. FEBS Letters. 213(1). 169–173. 8 indexed citations
18.
19.
Kitamura, Shigeto, et al.. (1982). 2-Hydroxysagamicin: A new antibiotic produced by mutational biosynthesis of Micromonospora sagamiensis.. The Journal of Antibiotics. 35(1). 94–97. 10 indexed citations
20.
Kase, Hiroshi, Shigeto Kitamura, & Kiyoshi Nakayama. (1982). PRODUCTION OF ANTIBIOTIC SU-2 COMPLEX BY A 2-DEOXYSTREPTAMINE IDIOTROPH OF MICROMONOSPORA SAGAMIENSIS. The Journal of Antibiotics. 35(4). 385–390. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason M. Conley Breakdown of academic impact, for papers by Yu Jin Hwang Breakdown of academic impact, for papers by Andrea Spinaci Breakdown of academic impact, for papers by Thomas P. Kemmer Breakdown of academic impact, for papers by Kuehl Fa Breakdown of academic impact, for papers by Isabelle Delton‐Vandenbroucke Breakdown of academic impact, for papers by Hyo Sang Jo Breakdown of academic impact, for papers by Luke J. Haslett Breakdown of academic impact, for papers by Violetta N. Pivtoraiko Breakdown of academic impact, for papers by Monika Bozem
Rankless by CCL
2026